
Milestones in IgAN & FSGS: Advancing Understanding and Possibilities
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
About this listen
Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research and potential treatment opportunities. The conversation will also delve into the evolving role of dual angiotensin/endothelin receptor antagonism for these conditions, highlighting the results from recent clinical trials and their impact on patient care. Don’t miss this opportunity to stay at the forefront of innovation in nephrology care.
Sponsored by Travere Therapeutics
No reviews yet